Extracellular matrix conditions T cells for adhesion to tissue interstitium.
The activation and differentiation of peripheral blood T cells (PBT) are known to correlate with increased surface expression and adhesive capacity of beta(1) integrins, which mediate adhesion to the extracellular matrix (ECM). However, little is known about the regulation of integrin expression, affinity, and avidity on tissue T cells after they are embedded in the interstitial ECM. In this study we show that tissue T cells, freshly isolated from their residence in the interstitial ECM of the intestinal lamina propria, express a distinct subset of functionally active integrins that contribute to enhanced adhesion to purified collagen, fibronectin, and cell-derived ECM when compared with freshly isolated, short term activated, and long term cultured PBT. Furthermore, integrin usage is distinct between circulating and tissue-derived T cells, in that lamina propria T cells prefer to bind to collagen, while PBT lymphoblasts choose fibronectin when presented with a complex, three-dimensional, cell-derived matrix. To identify the extrinsic factors that regulate the conversion from a nonadhesive PBT to highly adhesive tissue T cell, we demonstrate that activation of PBT in the presence of fibronectin or collagen rapidly generates a surface integrin expression profile, an integrin usage pattern, and adhesive capacity mirroring that of a tissue T cell. These results indicate that the tissue ECM microenvironment instructs newly arrived T cells for further interactions with the underlying matrix and thereby imprints them with a signature tissue adhesive phenotype.
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Kimberly A
KA
Krivacic
Alan D
AD
Levine
D002448:Cell Adhesion / Q000276:immunology / Q000502:physiology; D002450:Cell Communication / Q000276:immunology / Q000502:physiology*; D018929:Cell Culture Techniques; D002478:Cells, Cultured; D003094:Collagen / Q000737:chemistry / Q000502:physiology; D024042:Collagen Type I / Q000502:physiology; D003238:Connective Tissue / Q000737:chemistry / Q000276:immunology / Q000502:physiology*; D005109:Extracellular Matrix / Q000737:chemistry / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D005353:Fibronectins / Q000737:chemistry / Q000502:physiology; D006801:Humans; D016130:Immunophenotyping; D039041:Integrin alpha4beta1 / Q000096:biosynthesis / Q000097:blood / Q000502:physiology; D019012:Integrin beta1 / Q000096:biosynthesis / Q000097:blood / Q000502:physiology; D016023:Integrins / Q000096:biosynthesis / Q000097:blood / Q000502:physiology; D007413:Intestinal Mucosa / Q000737:chemistry / Q000166:cytology / Q000276:immunology / Q000502:physiology; D008024:Ligands; D008213:Lymphocyte Activation / Q000502:physiology; D011485:Protein Binding / Q000276:immunology / Q000502:physiology; D016176:T-Lymphocyte Subsets / Q000166:cytology / Q000378:metabolism / Q000502:physiology*
D024042:Collagen Type I; D005353:Fibronectins; D039041:Integrin alpha4beta1; D019012:Integrin beta1; D016023:Integrins; D008024:Ligands; D003094:Collagen